Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease

Author(s): Naomi M. Hamburg, Nicholas J. Leeper

Journal Name: Current Vascular Pharmacology

Volume 13 , Issue 3 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Peripheral artery disease (PAD) produces significant disability attributable to lower extremity ischemia. Limited treatment modalities exist to ameliorate clinical symptoms in patients with PAD. Growing evidence links microRNAs to key processes that govern disease expression in PAD including angiogenesis, endothelial function, inflammation, vascular regeneration, vascular smooth muscle cell function, restenosis, and mitochondrial function. MicroRNAs have been identified in circulation and may serve as novel biomarkers in PAD. This article reviews the potential contribution of microRNA to key pathways of disease development in PAD that may lead to microRNA-based diagnostic and therapeutic approaches.

Keywords: Biomarker, peripheral arterial disease, epigenetics.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 06 July, 2015
Page: [316 - 323]
Pages: 8
DOI: 10.2174/15701611113119990014
Price: $65

Article Metrics

PDF: 36